Publications by authors named "Michael GeiSSler"

Claim this Profile
M
Methodic aspects of influenza and respiratory syncytial virus detection in raw wastewater and presence in treatment plants in southeastern Germany.
Michael Geissler, Helene Berndt, Ella Herberger, Konrad Wilms, Roger Dumke

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial.
Klara Dorman, Stefan Boeck, Karel Caca, Maximilian Reichert, Thomas J Ettrich

Lancet Gastroenterol Hepatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114).
Kathrin Heinrich, Volker Heinemann, Sebastian Stintzing, Lothar Müller, Thomas J Ettrich

Oncol Res Treat· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food and Environmental Virology: Use of Passive Sampling to Characterize the Presence of SARS-CoV-2 and Other Viruses in Wastewater.
Michael Geissler, Robin Mayer, Björn Helm, Roger Dumke

Food Environ Virol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the sensitivity of droplet digital PCR for the quantification of SARS-CoV-2 in wastewater.
Magali de la Cruz Barron, David Kneis, Michael Geissler, Roger Dumke, Alexander Dalpke

Front Public Health· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enterococci, Gene-Carrying Enterococci, and Vancomycin Concentrations in the Influent of a Wastewater Treatment Plant in Southeast Germany.
Michael Geissler, Percy Schröttner, Reinhard Oertel, Roger Dumke

Microorganisms· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional and temporal differences in the relation between SARS-CoV-2 biomarkers in wastewater and estimated infection prevalence - Insights from long-term surveillance.
Björn Helm, Michael Geissler, Robin Mayer, Sara Schubert, Reinhard Oertel

Sci Total Environ· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Detection of SARS-CoV-2 and Influenza Virus in Wastewater of Two Cities in Southeastern Germany, January to May 2022.
Roger Dumke, Michael Geissler, Annett Skupin, Björn Helm, Robin Mayer

Int J Environ Res Public Health· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3).
Markus Moehler, Gunnar Folprecht, Volker Heinemann, Julian Walter Holch, Annett Maderer

Int J Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy.
Annabel H S Alig, Volker Heinemann, Michael Geissler, Ludwig Fischer von Weikersthal, Thomas Decker

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships Between Köhne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer.
Andrea Sartore-Bianchi, Pilar García-Alfonso, Michael Geissler, Claus-Henning Köhne, Marc Peeters

Clin Colorectal Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled and Local Delivery of Antibiotics by 3D Core/Shell Printed Hydrogel Scaffolds to Treat Soft Tissue Infections.
Ashwini Rahul Akkineni, Janina Spangenberg, Michael Geissler, Saskia Reichelt, Hubert Buechner

Pharmaceutics· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute transverse myelitis after COVID-19 pneumonia.
Maike Munz, Swen Wessendorf, Georgios Koretsis, Friedemann Tewald, Reem Baegi, Michael Geissler

J Neurol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC).
Carl Christoph Schimanski, Stefan Kasper, Susanna Hegewisch-Becker, Jan Schröder, Friedrich Overkamp

Oncoimmunology· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prerequisites of magnetic resonance imaging for treatment planning in locally advanced rectal cancer - Interdisciplinary recommendations].
Ulrike Attenberger, Claus Rödel, Michael Ghadimi, Pompilio Piso, Dirk Arnold, Michael Geissler

Z Gastroenterol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer.
Andreas W Berger, Daniel Schwerdel, Anke Reinacher-Schick, Waldemar Uhl, Hana Algül, Michael Geissler

Theranostics· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma.
Joerg T Hartmann, Hans-G Kopp, Viktor Gruenwald, Sophie Piperno-Neumann, Annegret Kunitz, Michael Geissler

Eur J Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship Between Tumor Response and Tumor-Related Symptoms in RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses From 3 Panitumumab Trials.
Julien Taieb, Michael Geissler, Fernando Rivera, Meinolf Karthaus, Richard Wilson

Clin Colorectal Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFOXIRI Plus Panitumumab As First-Line Treatment of Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109).
Dominik P Modest, Uwe M Martens, Jorge Riera-Knorrenschild, Jobst Greeve, Axel Florschütz, Michael Geissler

J Clin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.
Alexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian

J Immunother Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.
Thomas J Ettrich, Andreas W Berger, Lukas Perkhofer, Severin Daum, Alexander König, Michael Geissler

BMC Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib.
Martin Steins, Michael Thomas, Michael Geißler

Recent Results Cancer Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials.
Marc Peeters, Timothy Price, Julien Taieb, Michael Geissler, Fernando Rivera

Br J Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials.
Julien Taieb, Fernando Rivera, Salvatore Siena, Meinolf Karthaus, Manuel Valladares-Ayerbes, Michael Geissler

J Cancer Res Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study.
Arndt Vogel, Stefan Kasper, Michael Bitzer, Andreas Block, Marianne Sinn, Michael Geissler

Eur J Cancer· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis